# Study of TP-04 in Participants With Papulopustular Rosacea

> **NCT05838170** · PHASE2 · COMPLETED · sponsor: **Tarsus Pharmaceuticals, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** Lotilaner Gel, 2.0%
- **OTHER:** Vehicle control gel

## Key facts

- **NCT ID:** NCT05838170
- **Lead sponsor:** Tarsus Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-11-13
- **Final completion:** 2023-11-13
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05838170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05838170, "Study of TP-04 in Participants With Papulopustular Rosacea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05838170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*